Evidence map›Paper›PMID 31159151›Full record

ArticleInternational journal of molecular sciences2019

Inhibitory Effects of Quercetin and Its Human and Microbial Metabolites on Xanthine Oxidase Enzyme.

Violetta Mohos, Attila Pánovics, Eszter Fliszár-Nyúl, Gabriella Schilli, Csaba Hetényi, Přemysl Mladěnka, Paul W Needs, Paul A Kroon, Gábor Pethő, Miklós Poór

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 50 citations in OpenAlex.

  1. Oxidation-derived metabolites sustain the antioxidant network of quercetin.Journal of computer-aided molecular design · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Effect ofMedicina (Kaunas, Lithuania) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Violetta MohosDepartment of Pharmacology, University of Pécs, Faculty of Pharmacy, Szigeti út 12, H-7624 Pécs, Hungary. mohos.violetta@gytk.pte.hu.
Attila PánovicsDepartment of Pharmacology, University of Pécs, Faculty of Pharmacy, Szigeti út 12, H-7624 Pécs, Hungary. attilapanovics@gmail.com.
Eszter Fliszár-NyúlDepartment of Pharmacology, University of Pécs, Faculty of Pharmacy, Szigeti út 12, H-7624 Pécs, Hungary. eszter.nyul@aok.pte.hu.
Gabriella SchilliDepartment of Pharmacology and Pharmacotherapy, University of Pécs, Medical School, Szigeti út 12, H-7624 Pécs, Hungary. scgpecs@gmail.com.
Csaba HetényiDepartment of Pharmacology and Pharmacotherapy, University of Pécs, Medical School, Szigeti út 12, H-7624 Pécs, Hungary. csabahete@yahoo.com.ORCID 0000-0002-8013-971X
Přemysl MladěnkaDepartment of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. mladenkap@faf.cuni.cz.ORCID 0000-0002-6076-6900
Paul W NeedsQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UA, UK. paul.needs@quadram.ac.uk.
Paul A KroonQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UA, UK. paul.kroon@quadram.ac.uk.ORCID 0000-0002-9805-6947
Gábor PethőDepartment of Pharmacology, University of Pécs, Faculty of Pharmacy, Szigeti út 12, H-7624 Pécs, Hungary. gabor.petho@aok.pte.hu.
Miklós PoórDepartment of Pharmacology, University of Pécs, Faculty of Pharmacy, Szigeti út 12, H-7624 Pécs, Hungary. poor.miklos@pte.hu.
University of Pecs · HUNorwich Research Park · GBCharles University · CZ

Funding

European Social Fund EFOP-3.6.1.-16-2016-00004
6 · The paper itself

Abstract

Quercetin is an abundant flavonoid in nature and is used in several dietary supplements. Although quercetin is extensively metabolized by human enzymes and the colonic microflora, we have only few data regarding the pharmacokinetic interactions of its metabolites. Therefore, we investigated the interaction of human and microbial metabolites of quercetin with the xanthine oxidase enzyme. Inhibitory effects of five conjugates and 23 microbial metabolites were examined with 6-mercaptopurine and xanthine substrates (both at 5 μM), employing allopurinol as a positive control. Quercetin-3'-sulfate, isorhamnetin, tamarixetin, and pyrogallol proved to be strong inhibitors of xanthine oxidase. Sulfate and methyl conjugates were similarly strong inhibitors of both 6-mercaptopurine and xanthine oxidations (IC

Indexed as

AllopurinolCatalysisDose-Response Relationship, DrugEnzyme InhibitorsHumansModels, MolecularMolecular ConformationMolecular StructureOxidation-ReductionProtein BindingQuercetinStructure-Activity RelationshipXanthineXanthine OxidaseAllopurinolEnzyme InhibitorsQuercetinXanthineXanthine Oxidase6-mercaptopurineenzyme inhibitionpharmacokinetic interactionsquercetin metabolitesxanthinexanthine oxidase

Identifiers

PMID31159151
PMCPMC6600370
OpenAlexW2947056421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.